Thomas E. Robertson

Thomas Robertson practices at Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health.

Thomas Robertson's NPI, 1730575226, was assigned on April 10, 2015. Thomas Robertson graduated from University of Maryland School of Medicine in 2015. Thomas Robertson holds Pennsylvania license MD462937.

Thomas Robertson's primary practice is Allegheny General Hospital, at 320 East North Avenue, Pittsburgh, PA 15212 in Allegheny County. The practice phone is (412) 359-3131.

Thomas Robertson's primary practice is Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health. Thomas Robertson is also affiliated with West Penn Hospital. The medical group on file is AHN Primary Care - Family Med Associates at H+W Pavilion Bethel Park. Dmand AI also links Thomas Robertson to 1 more breast imaging center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Thomas Robertson practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Thomas Robertson's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Thomas Robertson is licensed in Pennsylvania.

CMS data shows 139 Medicare services from Thomas Robertson across 5 procedure codes in 2024, for 72 Medicare patients. Medicare paid $10,705 for them.

CMS counts 72 Medicare patients who saw Thomas Robertson in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high blood pressure, and 61% have high cholesterol. 39% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Thomas Robertson's median patient age at 66, with 46% women.

In 2024, Thomas Robertson wrote 435 Medicare Part D claims for 95 patients. 80% of them were for generic drugs. CMS names the drug for 194 of them, across 11 drugs with 11 or more claims each, at $28,627 in total drug cost. In 2023, CMS named 279 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Thomas Robertson for performance year 2024, reported through an alternative payment model (APM). Thomas Robertson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Thomas Robertson, published from 2017 to 2025. 2024 was the busiest year, with 3. The most frequent topics are Point-of-Care Systems, Telemedicine and Ultrasonography. Thomas Robertson has published most often in POCUS J. Thomas Robertson's most frequent co-authors are Divya R. Bhamidipati, MD, Michelle J. Fleshner, MD and Ayako Wendy Fujita, MD, MS.

CMS Open Payments shows 43 general payments to Thomas Robertson from 2 drug and device companies from 2024 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Indivior Inc. paid the most, $13,378.

Thomas Robertson graduated from University of Maryland School of Medicine in 2015.